[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fcB4GW3a2XWr9xXAQB7SjhzeHiCBeeazRCivwvqzTA7M":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center",[4],68,false,5,7,14267,15,30,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Endothelial Dysfunction",3,{"name":18,"count":16},"Atherosclerosis",{"name":20,"count":21},"Bone and Joint Infection",2,{"name":23,"count":21},"Coronary Arteriosclerosis",{"name":25,"count":21},"End-stage Renal Disease",{"name":27,"count":21},"Overactive Bladder",{"name":29,"count":21},"Inflammation",{"name":31,"count":21},"Mucopolysaccharidosis I",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT04037605","Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","2022-07-24","Ketoconazole Pill",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05753215","Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection","2026-02","Omadacycline Pill",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT03153319","Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI","2027-01","Adalimumab Injection [Humira]",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06333041","Study of Cannabidiol in Sanfilippo Syndrome","2027-04","Epidiolex",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,87,129,147,171,189,221,239,257,275,293,311,329,347,365,383,421,448,472,498,516,542,569,587,612,637,662,680,698,716,741,766,792,818,847,871,896,921,947,965,990,1015,1038,1066,1084,1112,1139,1157,1183,1211,1229,1255,1280,1298,1325,1343,1361,1385,1411],{"intervention":52,"totalTrials":62,"cells":63},1,{"EARLY_PHASE1":64,"PHASE1":67,"PHASE2":69,"PHASE3":71,"PHASE4":83,"NA":85},{"trials":65,"activeCount":66},[],0,{"trials":68,"activeCount":66},[],{"trials":70,"activeCount":66},[],{"trials":72,"activeCount":62,"soonestReadout":51},[73],{"nctId":49,"briefTitle":50,"status":74,"phases":75,"primaryCompletion":51,"completion":76,"start":77,"enrollment":78,"conditions":79,"interventions":82},"RECRUITING",[56,57],"2028-12","2026-04",35,[80,81],"Sanfilippo Syndrome","Mucopolysaccharidosis III",[52],{"trials":84,"activeCount":66},[],{"trials":86,"activeCount":66},[],{"intervention":88,"totalTrials":21,"cells":89},"Saline solution for",{"EARLY_PHASE1":90,"PHASE1":109,"PHASE2":111,"PHASE3":123,"PHASE4":125,"NA":127},{"trials":91,"activeCount":62,"soonestReadout":36},[92],{"nctId":34,"briefTitle":35,"status":93,"phases":94,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":97,"interventions":99},"ACTIVE_NOT_RECRUITING",[54],"2026-06-24","2020-02-09",[98],"Sleep Restriction",[37,100,101,102,103,104,105,106,107,108,88],"Ganirelix","Dexamethasone Pill","Dexamethasone","Cosyntropin Injectable Product","Recombinant Human Luteinizing Hormone","Hydrocortisone","Gonadorelin","Corticorelin","Saline Solution",{"trials":110,"activeCount":66},[],{"trials":112,"activeCount":62,"soonestReadout":46},[113],{"nctId":44,"briefTitle":45,"status":93,"phases":114,"primaryCompletion":46,"completion":115,"start":116,"enrollment":117,"conditions":118,"interventions":121},[55,56],"2027-02","2017-06-05",14,[31,119,120],"Mucopolysaccharidosis II","Mucopolysaccharidosis VI",[47,122],"Saline Solution for",{"trials":124,"activeCount":66},[],{"trials":126,"activeCount":66},[],{"trials":128,"activeCount":66},[],{"intervention":47,"totalTrials":62,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":141,"PHASE4":143,"NA":145},{"trials":132,"activeCount":66},[],{"trials":134,"activeCount":66},[],{"trials":136,"activeCount":62,"soonestReadout":46},[137],{"nctId":44,"briefTitle":45,"status":93,"phases":138,"primaryCompletion":46,"completion":115,"start":116,"enrollment":117,"conditions":139,"interventions":140},[55,56],[31,119,120],[47,122],{"trials":142,"activeCount":66},[],{"trials":144,"activeCount":66},[],{"trials":146,"activeCount":66},[],{"intervention":42,"totalTrials":62,"cells":148},{"EARLY_PHASE1":149,"PHASE1":151,"PHASE2":153,"PHASE3":165,"PHASE4":167,"NA":169},{"trials":150,"activeCount":66},[],{"trials":152,"activeCount":66},[],{"trials":154,"activeCount":62,"soonestReadout":41},[155],{"nctId":39,"briefTitle":40,"status":93,"phases":156,"primaryCompletion":41,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":163},[56],"2026-06","2023-05-09",180,[161,162,20],"Bone Infection","Joint Infection",[42,164],"Standard of Care",{"trials":166,"activeCount":66},[],{"trials":168,"activeCount":66},[],{"trials":170,"activeCount":66},[],{"intervention":164,"totalTrials":62,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":183,"PHASE4":185,"NA":187},{"trials":174,"activeCount":66},[],{"trials":176,"activeCount":66},[],{"trials":178,"activeCount":62,"soonestReadout":41},[179],{"nctId":39,"briefTitle":40,"status":93,"phases":180,"primaryCompletion":41,"completion":157,"start":158,"enrollment":159,"conditions":181,"interventions":182},[56],[161,162,20],[42,164],{"trials":184,"activeCount":66},[],{"trials":186,"activeCount":66},[],{"trials":188,"activeCount":66},[],{"intervention":105,"totalTrials":21,"cells":190},{"EARLY_PHASE1":191,"PHASE1":211,"PHASE2":213,"PHASE3":215,"PHASE4":217,"NA":219},{"trials":192,"activeCount":62,"soonestReadout":36},[193,197],{"nctId":34,"briefTitle":35,"status":93,"phases":194,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":195,"interventions":196},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"nctId":198,"briefTitle":199,"status":200,"phases":201,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":206,"interventions":208},"NCT02256865","Hormonal Mechanisms of Sleep Restriction","COMPLETED",[54],"2017-11","2023-10","2014-10",40,[207],"Insulin Resistance",[209,105,210],"Ketoconazole","Testosterone",{"trials":212,"activeCount":66},[],{"trials":214,"activeCount":66},[],{"trials":216,"activeCount":66},[],{"trials":218,"activeCount":66},[],{"trials":220,"activeCount":66},[],{"intervention":37,"totalTrials":62,"cells":222},{"EARLY_PHASE1":223,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":224,"activeCount":62,"soonestReadout":36},[225],{"nctId":34,"briefTitle":35,"status":93,"phases":226,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":227,"interventions":228},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":230,"activeCount":66},[],{"trials":232,"activeCount":66},[],{"trials":234,"activeCount":66},[],{"trials":236,"activeCount":66},[],{"trials":238,"activeCount":66},[],{"intervention":100,"totalTrials":62,"cells":240},{"EARLY_PHASE1":241,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":253,"NA":255},{"trials":242,"activeCount":62,"soonestReadout":36},[243],{"nctId":34,"briefTitle":35,"status":93,"phases":244,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":245,"interventions":246},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":248,"activeCount":66},[],{"trials":250,"activeCount":66},[],{"trials":252,"activeCount":66},[],{"trials":254,"activeCount":66},[],{"trials":256,"activeCount":66},[],{"intervention":101,"totalTrials":62,"cells":258},{"EARLY_PHASE1":259,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":273},{"trials":260,"activeCount":62,"soonestReadout":36},[261],{"nctId":34,"briefTitle":35,"status":93,"phases":262,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":263,"interventions":264},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":266,"activeCount":66},[],{"trials":268,"activeCount":66},[],{"trials":270,"activeCount":66},[],{"trials":272,"activeCount":66},[],{"trials":274,"activeCount":66},[],{"intervention":102,"totalTrials":62,"cells":276},{"EARLY_PHASE1":277,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":289,"NA":291},{"trials":278,"activeCount":62,"soonestReadout":36},[279],{"nctId":34,"briefTitle":35,"status":93,"phases":280,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":281,"interventions":282},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":284,"activeCount":66},[],{"trials":286,"activeCount":66},[],{"trials":288,"activeCount":66},[],{"trials":290,"activeCount":66},[],{"trials":292,"activeCount":66},[],{"intervention":103,"totalTrials":62,"cells":294},{"EARLY_PHASE1":295,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":307,"NA":309},{"trials":296,"activeCount":62,"soonestReadout":36},[297],{"nctId":34,"briefTitle":35,"status":93,"phases":298,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":299,"interventions":300},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":302,"activeCount":66},[],{"trials":304,"activeCount":66},[],{"trials":306,"activeCount":66},[],{"trials":308,"activeCount":66},[],{"trials":310,"activeCount":66},[],{"intervention":104,"totalTrials":62,"cells":312},{"EARLY_PHASE1":313,"PHASE1":319,"PHASE2":321,"PHASE3":323,"PHASE4":325,"NA":327},{"trials":314,"activeCount":62,"soonestReadout":36},[315],{"nctId":34,"briefTitle":35,"status":93,"phases":316,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":317,"interventions":318},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":320,"activeCount":66},[],{"trials":322,"activeCount":66},[],{"trials":324,"activeCount":66},[],{"trials":326,"activeCount":66},[],{"trials":328,"activeCount":66},[],{"intervention":106,"totalTrials":62,"cells":330},{"EARLY_PHASE1":331,"PHASE1":337,"PHASE2":339,"PHASE3":341,"PHASE4":343,"NA":345},{"trials":332,"activeCount":62,"soonestReadout":36},[333],{"nctId":34,"briefTitle":35,"status":93,"phases":334,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":335,"interventions":336},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":338,"activeCount":66},[],{"trials":340,"activeCount":66},[],{"trials":342,"activeCount":66},[],{"trials":344,"activeCount":66},[],{"trials":346,"activeCount":66},[],{"intervention":107,"totalTrials":62,"cells":348},{"EARLY_PHASE1":349,"PHASE1":355,"PHASE2":357,"PHASE3":359,"PHASE4":361,"NA":363},{"trials":350,"activeCount":62,"soonestReadout":36},[351],{"nctId":34,"briefTitle":35,"status":93,"phases":352,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":353,"interventions":354},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":356,"activeCount":66},[],{"trials":358,"activeCount":66},[],{"trials":360,"activeCount":66},[],{"trials":362,"activeCount":66},[],{"trials":364,"activeCount":66},[],{"intervention":108,"totalTrials":62,"cells":366},{"EARLY_PHASE1":367,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":379,"NA":381},{"trials":368,"activeCount":62,"soonestReadout":36},[369],{"nctId":34,"briefTitle":35,"status":93,"phases":370,"primaryCompletion":36,"completion":95,"start":96,"enrollment":8,"conditions":371,"interventions":372},[54],[98],[37,100,101,102,103,104,105,106,107,108,88],{"trials":374,"activeCount":66},[],{"trials":376,"activeCount":66},[],{"trials":378,"activeCount":66},[],{"trials":380,"activeCount":66},[],{"trials":382,"activeCount":66},[],{"intervention":384,"totalTrials":21,"cells":385},"Warfarin",{"EARLY_PHASE1":386,"PHASE1":388,"PHASE2":390,"PHASE3":392,"PHASE4":394,"NA":419},{"trials":387,"activeCount":66},[],{"trials":389,"activeCount":66},[],{"trials":391,"activeCount":66},[],{"trials":393,"activeCount":66},[],{"trials":395,"activeCount":66},[396,406],{"nctId":397,"briefTitle":398,"status":200,"phases":399,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":404},"NCT02376010","Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium",[58],"2018-04-01","2015-04-02",110,[18],[405,384],"rivaroxaban",{"nctId":407,"briefTitle":408,"status":200,"phases":409,"primaryCompletion":410,"completion":411,"start":412,"enrollment":413,"conditions":414,"interventions":416},"NCT02090075","Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque",[58],"2016-12-27","2017-04-05","2014-09",66,[415],"Atrial Fibrillation",[417,418],"apixaban","warfarin",{"trials":420,"activeCount":66},[],{"intervention":422,"totalTrials":62,"cells":423},"LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel",{"EARLY_PHASE1":424,"PHASE1":426,"PHASE2":428,"PHASE3":430,"PHASE4":432,"NA":446},{"trials":425,"activeCount":66},[],{"trials":427,"activeCount":66},[],{"trials":429,"activeCount":66},[],{"trials":431,"activeCount":66},[],{"trials":433,"activeCount":66},[434],{"nctId":435,"briefTitle":436,"status":200,"phases":437,"primaryCompletion":438,"completion":438,"start":439,"enrollment":440,"conditions":441,"interventions":445},"NCT04203225","Comparison of Two Application Techniques for LET Gel",[58],"2019-11-12","2017-05-22",48,[442,443,444],"Lacerations","Pain, Procedural","LET",[422],{"trials":447,"activeCount":66},[],{"intervention":449,"totalTrials":62,"cells":450},"Stiolto Respimat",{"EARLY_PHASE1":451,"PHASE1":453,"PHASE2":455,"PHASE3":457,"PHASE4":459,"NA":470},{"trials":452,"activeCount":66},[],{"trials":454,"activeCount":66},[],{"trials":456,"activeCount":66},[],{"trials":458,"activeCount":66},[],{"trials":460,"activeCount":66},[461],{"nctId":462,"briefTitle":463,"status":200,"phases":464,"primaryCompletion":465,"completion":465,"start":466,"enrollment":117,"conditions":467,"interventions":469},"NCT02845752","The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease",[58],"2018-08-06","2017-03-01",[468],"Chronic Obstructive Pulmonary Disease",[449],{"trials":471,"activeCount":66},[],{"intervention":473,"totalTrials":62,"cells":474},"Solumedrol 20mg",{"EARLY_PHASE1":475,"PHASE1":477,"PHASE2":479,"PHASE3":481,"PHASE4":483,"NA":496},{"trials":476,"activeCount":66},[],{"trials":478,"activeCount":66},[],{"trials":480,"activeCount":66},[],{"trials":482,"activeCount":66},[],{"trials":484,"activeCount":66},[485],{"nctId":486,"briefTitle":487,"status":200,"phases":488,"primaryCompletion":489,"completion":489,"start":490,"enrollment":491,"conditions":492,"interventions":494},"NCT03152474","Adrenal Cortical Function and Vitamin A Deficiency in Sepsis",[58],"2000-01","1993-02",300,[493],"Sepsis",[473,495],"Vitamin A 100,000 IU",{"trials":497,"activeCount":66},[],{"intervention":495,"totalTrials":62,"cells":499},{"EARLY_PHASE1":500,"PHASE1":502,"PHASE2":504,"PHASE3":506,"PHASE4":508,"NA":514},{"trials":501,"activeCount":66},[],{"trials":503,"activeCount":66},[],{"trials":505,"activeCount":66},[],{"trials":507,"activeCount":66},[],{"trials":509,"activeCount":66},[510],{"nctId":486,"briefTitle":487,"status":200,"phases":511,"primaryCompletion":489,"completion":489,"start":490,"enrollment":491,"conditions":512,"interventions":513},[58],[493],[473,495],{"trials":515,"activeCount":66},[],{"intervention":517,"totalTrials":62,"cells":518},"Vascepa",{"EARLY_PHASE1":519,"PHASE1":521,"PHASE2":523,"PHASE3":525,"PHASE4":527,"NA":540},{"trials":520,"activeCount":66},[],{"trials":522,"activeCount":66},[],{"trials":524,"activeCount":66},[],{"trials":526,"activeCount":66},[],{"trials":528,"activeCount":66},[529],{"nctId":530,"briefTitle":531,"status":200,"phases":532,"primaryCompletion":533,"completion":534,"start":535,"enrollment":536,"conditions":537,"interventions":539},"NCT02926027","Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy",[58],"2020-05-15","2020-08-15","2017-03-28",80,[538],"Hypertriglyceridemia",[517],{"trials":541,"activeCount":66},[],{"intervention":543,"totalTrials":62,"cells":544},"Fentanyl",{"EARLY_PHASE1":545,"PHASE1":547,"PHASE2":549,"PHASE3":551,"PHASE4":553,"NA":567},{"trials":546,"activeCount":66},[],{"trials":548,"activeCount":66},[],{"trials":550,"activeCount":66},[],{"trials":552,"activeCount":66},[],{"trials":554,"activeCount":66},[555],{"nctId":556,"briefTitle":557,"status":200,"phases":558,"primaryCompletion":559,"completion":560,"start":561,"enrollment":562,"conditions":563,"interventions":565},"NCT01708122","Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures",[58],"2013-03","2014-02","2009-05",71,[564],"Pain",[543,566],"saline",{"trials":568,"activeCount":66},[],{"intervention":566,"totalTrials":62,"cells":570},{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":585},{"trials":572,"activeCount":66},[],{"trials":574,"activeCount":66},[],{"trials":576,"activeCount":66},[],{"trials":578,"activeCount":66},[],{"trials":580,"activeCount":66},[581],{"nctId":556,"briefTitle":557,"status":200,"phases":582,"primaryCompletion":559,"completion":560,"start":561,"enrollment":562,"conditions":583,"interventions":584},[58],[564],[543,566],{"trials":586,"activeCount":66},[],{"intervention":588,"totalTrials":62,"cells":589},"aged garlic extract",{"EARLY_PHASE1":590,"PHASE1":592,"PHASE2":594,"PHASE3":596,"PHASE4":598,"NA":610},{"trials":591,"activeCount":66},[],{"trials":593,"activeCount":66},[],{"trials":595,"activeCount":66},[],{"trials":597,"activeCount":66},[],{"trials":599,"activeCount":66},[600],{"nctId":601,"briefTitle":602,"status":200,"phases":603,"primaryCompletion":604,"completion":604,"start":605,"enrollment":606,"conditions":607,"interventions":609},"NCT01534910","Effect of Aged Garlic Extract on Atherosclerosis",[58],"2014-12","2012-05",65,[608],"Metabolic Syndrome",[588],{"trials":611,"activeCount":66},[],{"intervention":613,"totalTrials":62,"cells":614},"Colchicine 0.5 MG",{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":623,"NA":635},{"trials":616,"activeCount":66},[],{"trials":618,"activeCount":66},[],{"trials":620,"activeCount":66},[],{"trials":622,"activeCount":66},[],{"trials":624,"activeCount":66},[625],{"nctId":626,"briefTitle":627,"status":200,"phases":628,"primaryCompletion":629,"completion":629,"start":630,"enrollment":631,"conditions":632,"interventions":634},"NCT06342609","Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease",[58],"2024-09-07","2023-03-15",84,[633],"Coronary Artery Disease",[613],{"trials":636,"activeCount":66},[],{"intervention":638,"totalTrials":62,"cells":639},"ammonium chloride or sodium citrate\u002Fcitric acid",{"EARLY_PHASE1":640,"PHASE1":642,"PHASE2":644,"PHASE3":646,"PHASE4":648,"NA":660},{"trials":641,"activeCount":66},[],{"trials":643,"activeCount":66},[],{"trials":645,"activeCount":66},[],{"trials":647,"activeCount":66},[],{"trials":649,"activeCount":66},[650],{"nctId":651,"briefTitle":652,"status":200,"phases":653,"primaryCompletion":654,"completion":654,"start":655,"enrollment":656,"conditions":657,"interventions":658},"NCT00586131","Arterial pH and Total Body Nitrogen Balances in APD",[58],"2008-04","2003-09",8,[25],[638,659],"Sodium citrate\u002Fcitratic acid",{"trials":661,"activeCount":66},[],{"intervention":659,"totalTrials":62,"cells":663},{"EARLY_PHASE1":664,"PHASE1":666,"PHASE2":668,"PHASE3":670,"PHASE4":672,"NA":678},{"trials":665,"activeCount":66},[],{"trials":667,"activeCount":66},[],{"trials":669,"activeCount":66},[],{"trials":671,"activeCount":66},[],{"trials":673,"activeCount":66},[674],{"nctId":651,"briefTitle":652,"status":200,"phases":675,"primaryCompletion":654,"completion":654,"start":655,"enrollment":656,"conditions":676,"interventions":677},[58],[25],[638,659],{"trials":679,"activeCount":66},[],{"intervention":405,"totalTrials":62,"cells":681},{"EARLY_PHASE1":682,"PHASE1":684,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":696},{"trials":683,"activeCount":66},[],{"trials":685,"activeCount":66},[],{"trials":687,"activeCount":66},[],{"trials":689,"activeCount":66},[],{"trials":691,"activeCount":66},[692],{"nctId":397,"briefTitle":398,"status":200,"phases":693,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":694,"interventions":695},[58],[18],[405,384],{"trials":697,"activeCount":66},[],{"intervention":417,"totalTrials":62,"cells":699},{"EARLY_PHASE1":700,"PHASE1":702,"PHASE2":704,"PHASE3":706,"PHASE4":708,"NA":714},{"trials":701,"activeCount":66},[],{"trials":703,"activeCount":66},[],{"trials":705,"activeCount":66},[],{"trials":707,"activeCount":66},[],{"trials":709,"activeCount":66},[710],{"nctId":407,"briefTitle":408,"status":200,"phases":711,"primaryCompletion":410,"completion":411,"start":412,"enrollment":413,"conditions":712,"interventions":713},[58],[415],[417,418],{"trials":715,"activeCount":66},[],{"intervention":717,"totalTrials":62,"cells":718},"Treprostinil",{"EARLY_PHASE1":719,"PHASE1":721,"PHASE2":723,"PHASE3":725,"PHASE4":727,"NA":739},{"trials":720,"activeCount":66},[],{"trials":722,"activeCount":66},[],{"trials":724,"activeCount":66},[],{"trials":726,"activeCount":66},[],{"trials":728,"activeCount":66},[729],{"nctId":730,"briefTitle":731,"status":200,"phases":732,"primaryCompletion":733,"completion":733,"start":734,"enrollment":735,"conditions":736,"interventions":738},"NCT01268553","Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication",[58],"2016-10-05","2010-08",6,[737],"Pulmonary Arterial Hypertension",[717],{"trials":740,"activeCount":66},[],{"intervention":742,"totalTrials":62,"cells":743},"Semaglutide 2 MG\u002F1.5 ML Subcutaneous Solution",{"EARLY_PHASE1":744,"PHASE1":746,"PHASE2":748,"PHASE3":750,"PHASE4":752,"NA":764},{"trials":745,"activeCount":66},[],{"trials":747,"activeCount":66},[],{"trials":749,"activeCount":66},[],{"trials":751,"activeCount":66},[],{"trials":753,"activeCount":66},[754],{"nctId":755,"briefTitle":756,"status":200,"phases":757,"primaryCompletion":758,"completion":758,"start":759,"enrollment":760,"conditions":761,"interventions":763},"NCT03985384","Semaglutide Treatment On Coronary Progression",[58],"2022-12-27","2019-04-30",140,[762,633],"Type 2 Diabetes",[742],{"trials":765,"activeCount":66},[],{"intervention":767,"totalTrials":62,"cells":768},"Ketamine",{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":773,"PHASE3":775,"PHASE4":788,"NA":790},{"trials":770,"activeCount":66},[],{"trials":772,"activeCount":66},[],{"trials":774,"activeCount":66},[],{"trials":776,"activeCount":66},[777],{"nctId":778,"briefTitle":779,"status":200,"phases":780,"primaryCompletion":781,"completion":782,"start":783,"enrollment":784,"conditions":785,"interventions":787},"NCT02920528","Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain",[57],"2018-06-22","2019-09-01","2017-05-01",106,[786],"Chronic Pain",[767],{"trials":789,"activeCount":66},[],{"trials":791,"activeCount":66},[],{"intervention":793,"totalTrials":62,"cells":794},"Prochlorperazine",{"EARLY_PHASE1":795,"PHASE1":797,"PHASE2":799,"PHASE3":801,"PHASE4":814,"NA":816},{"trials":796,"activeCount":66},[],{"trials":798,"activeCount":66},[],{"trials":800,"activeCount":66},[],{"trials":802,"activeCount":66},[803],{"nctId":804,"briefTitle":805,"status":806,"phases":807,"primaryCompletion":808,"completion":809,"start":810,"enrollment":536,"conditions":811,"interventions":813},"NCT02779959","Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT","UNKNOWN",[57],"2017-10","2018-04","2016-04",[812],"Migraine Disorders",[793],{"trials":815,"activeCount":66},[],{"trials":817,"activeCount":66},[],{"intervention":819,"totalTrials":62,"cells":820},"pentoxiphylline",{"EARLY_PHASE1":821,"PHASE1":823,"PHASE2":825,"PHASE3":827,"PHASE4":843,"NA":845},{"trials":822,"activeCount":66},[],{"trials":824,"activeCount":66},[],{"trials":826,"activeCount":66},[],{"trials":828,"activeCount":66},[829],{"nctId":830,"briefTitle":831,"status":200,"phases":832,"primaryCompletion":833,"completion":834,"start":835,"enrollment":836,"conditions":837,"interventions":842},"NCT00561093","Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients",[57],"2010-10","2011-05","2008-02",93,[838,839,29,840,841],"Hypoalbuminemia","Protein-energy Malnutrition","Oxidative Stress","Chronic Kidney Disease (CKD) Hemodialysis",[819],{"trials":844,"activeCount":66},[],{"trials":846,"activeCount":66},[],{"intervention":848,"totalTrials":62,"cells":849},"Somatropin",{"EARLY_PHASE1":850,"PHASE1":852,"PHASE2":854,"PHASE3":856,"PHASE4":867,"NA":869},{"trials":851,"activeCount":66},[],{"trials":853,"activeCount":66},[],{"trials":855,"activeCount":66},[],{"trials":857,"activeCount":66},[858],{"nctId":859,"briefTitle":860,"status":861,"phases":862,"primaryCompletion":863,"completion":863,"start":864,"enrollment":21,"conditions":865,"interventions":866},"NCT00748969","Clinical Trial of Growth Hormone in MPS I, II, and VI","TERMINATED",[56,57],"2013-09","2008-11",[31,119,120],[848],{"trials":868,"activeCount":66},[],{"trials":870,"activeCount":66},[],{"intervention":872,"totalTrials":62,"cells":873},"daptomycin",{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":892,"NA":894},{"trials":875,"activeCount":66},[],{"trials":877,"activeCount":66},[],{"trials":879,"activeCount":66},[],{"trials":881,"activeCount":66},[882],{"nctId":883,"briefTitle":884,"status":200,"phases":885,"primaryCompletion":833,"completion":833,"start":886,"enrollment":12,"conditions":887,"interventions":891},"NCT00701636","Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery",[57],"2008-07",[888,889,890],"Late Effects of Surgery","Staphylococcus Aureus","Surgical Site Infection",[872],{"trials":893,"activeCount":66},[],{"trials":895,"activeCount":66},[],{"intervention":897,"totalTrials":62,"cells":898},"Tedizolid",{"EARLY_PHASE1":899,"PHASE1":901,"PHASE2":903,"PHASE3":915,"PHASE4":917,"NA":919},{"trials":900,"activeCount":66},[],{"trials":902,"activeCount":66},[],{"trials":904,"activeCount":66},[905],{"nctId":906,"briefTitle":907,"status":200,"phases":908,"primaryCompletion":909,"completion":910,"start":911,"enrollment":912,"conditions":913,"interventions":914},"NCT03009045","Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)",[56],"2021-03-23","2021-08-06","2017-02-06",44,[20],[897],{"trials":916,"activeCount":66},[],{"trials":918,"activeCount":66},[],{"trials":920,"activeCount":66},[],{"intervention":922,"totalTrials":62,"cells":923},"Acetylcysteine",{"EARLY_PHASE1":924,"PHASE1":926,"PHASE2":928,"PHASE3":941,"PHASE4":943,"NA":945},{"trials":925,"activeCount":66},[],{"trials":927,"activeCount":66},[],{"trials":929,"activeCount":66},[930],{"nctId":931,"briefTitle":932,"status":200,"phases":933,"primaryCompletion":934,"completion":934,"start":935,"enrollment":936,"conditions":937,"interventions":939},"NCT04918719","Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke",[56],"2024-09-17","2023-11-02",4,[938],"Acute Ischemic Stroke",[922,940],"Dextrose in Water",{"trials":942,"activeCount":66},[],{"trials":944,"activeCount":66},[],{"trials":946,"activeCount":66},[],{"intervention":940,"totalTrials":62,"cells":948},{"EARLY_PHASE1":949,"PHASE1":951,"PHASE2":953,"PHASE3":959,"PHASE4":961,"NA":963},{"trials":950,"activeCount":66},[],{"trials":952,"activeCount":66},[],{"trials":954,"activeCount":66},[955],{"nctId":931,"briefTitle":932,"status":200,"phases":956,"primaryCompletion":934,"completion":934,"start":935,"enrollment":936,"conditions":957,"interventions":958},[56],[938],[922,940],{"trials":960,"activeCount":66},[],{"trials":962,"activeCount":66},[],{"trials":964,"activeCount":66},[],{"intervention":966,"totalTrials":62,"cells":967},"Interferon gamma-1b",{"EARLY_PHASE1":968,"PHASE1":970,"PHASE2":972,"PHASE3":984,"PHASE4":986,"NA":988},{"trials":969,"activeCount":66},[],{"trials":971,"activeCount":66},[],{"trials":973,"activeCount":66},[974],{"nctId":975,"briefTitle":976,"status":200,"phases":977,"primaryCompletion":978,"completion":979,"start":980,"enrollment":8,"conditions":981,"interventions":983},"NCT02666768","ACTIMMUNE in Intermediate Osteopetrosis",[56],"2019-03-11","2019-04-11","2016-02-22",[982],"Osteopetrosis",[966],{"trials":985,"activeCount":66},[],{"trials":987,"activeCount":66},[],{"trials":989,"activeCount":66},[],{"intervention":991,"totalTrials":62,"cells":992},"Psilocybin",{"EARLY_PHASE1":993,"PHASE1":995,"PHASE2":997,"PHASE3":1009,"PHASE4":1011,"NA":1013},{"trials":994,"activeCount":66},[],{"trials":996,"activeCount":66},[],{"trials":998,"activeCount":66},[999],{"nctId":1000,"briefTitle":1001,"status":200,"phases":1002,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1006,"interventions":1008},"NCT00302744","Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety",[55,56],"2008-12","2004-04",12,[1007],"Anxiety",[991],{"trials":1010,"activeCount":66},[],{"trials":1012,"activeCount":66},[],{"trials":1014,"activeCount":66},[],{"intervention":1016,"totalTrials":62,"cells":1017},"BPS-314d-MR",{"EARLY_PHASE1":1018,"PHASE1":1020,"PHASE2":1022,"PHASE3":1032,"PHASE4":1034,"NA":1036},{"trials":1019,"activeCount":66},[],{"trials":1021,"activeCount":66},[],{"trials":1023,"activeCount":66},[1024],{"nctId":1025,"briefTitle":1026,"status":200,"phases":1027,"primaryCompletion":1028,"completion":1028,"start":1029,"enrollment":62,"conditions":1030,"interventions":1031},"NCT01966302","Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)",[56],"2019-06-02","2013-11",[737],[1016],{"trials":1033,"activeCount":66},[],{"trials":1035,"activeCount":66},[],{"trials":1037,"activeCount":66},[],{"intervention":1039,"totalTrials":62,"cells":1040},"Eyedrop",{"EARLY_PHASE1":1041,"PHASE1":1043,"PHASE2":1045,"PHASE3":1060,"PHASE4":1062,"NA":1064},{"trials":1042,"activeCount":66},[],{"trials":1044,"activeCount":66},[],{"trials":1046,"activeCount":66},[1047],{"nctId":1048,"briefTitle":1049,"status":806,"phases":1050,"primaryCompletion":1051,"completion":1052,"start":1053,"enrollment":1054,"conditions":1055,"interventions":1058},"NCT03206723","Bandage Contact Lenses for Corneal Abrasions",[56],"2018-12-31","2019-03-01","2017-07-01",60,[1056,1057],"Corneal Abrasion","Eye Trauma",[1039,1059],"Hydrocodone",{"trials":1061,"activeCount":66},[],{"trials":1063,"activeCount":66},[],{"trials":1065,"activeCount":66},[],{"intervention":1059,"totalTrials":62,"cells":1067},{"EARLY_PHASE1":1068,"PHASE1":1070,"PHASE2":1072,"PHASE3":1078,"PHASE4":1080,"NA":1082},{"trials":1069,"activeCount":66},[],{"trials":1071,"activeCount":66},[],{"trials":1073,"activeCount":66},[1074],{"nctId":1048,"briefTitle":1049,"status":806,"phases":1075,"primaryCompletion":1051,"completion":1052,"start":1053,"enrollment":1054,"conditions":1076,"interventions":1077},[56],[1056,1057],[1039,1059],{"trials":1079,"activeCount":66},[],{"trials":1081,"activeCount":66},[],{"trials":1083,"activeCount":66},[],{"intervention":1085,"totalTrials":62,"cells":1086},"Povidone-Iodine",{"EARLY_PHASE1":1087,"PHASE1":1089,"PHASE2":1091,"PHASE3":1106,"PHASE4":1108,"NA":1110},{"trials":1088,"activeCount":66},[],{"trials":1090,"activeCount":66},[],{"trials":1092,"activeCount":66},[1093],{"nctId":1094,"briefTitle":1095,"status":200,"phases":1096,"primaryCompletion":1097,"completion":1097,"start":1098,"enrollment":1099,"conditions":1100,"interventions":1105},"NCT00386958","A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers",[56],"2006-01","2002-11",172,[1101,1102,1103,1104],"Infected Corneal Ulcers","Bacterial Keratitis","Corneal Ulcer","Childhood Blindness",[1085],{"trials":1107,"activeCount":66},[],{"trials":1109,"activeCount":66},[],{"trials":1111,"activeCount":66},[],{"intervention":1113,"totalTrials":62,"cells":1114},"deferasirox",{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1133,"PHASE4":1135,"NA":1137},{"trials":1116,"activeCount":66},[],{"trials":1118,"activeCount":66},[],{"trials":1120,"activeCount":66},[1121],{"nctId":1122,"briefTitle":1123,"status":200,"phases":1124,"primaryCompletion":1125,"completion":1126,"start":1127,"enrollment":1128,"conditions":1129,"interventions":1131},"NCT00419770","The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study",[56],"2009-12","2010-12","2007-10",20,[1130],"Mucormycosis",[1113,1132],"Liposomal amphotericin B",{"trials":1134,"activeCount":66},[],{"trials":1136,"activeCount":66},[],{"trials":1138,"activeCount":66},[],{"intervention":1132,"totalTrials":62,"cells":1140},{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1151,"PHASE4":1153,"NA":1155},{"trials":1142,"activeCount":66},[],{"trials":1144,"activeCount":66},[],{"trials":1146,"activeCount":66},[1147],{"nctId":1122,"briefTitle":1123,"status":200,"phases":1148,"primaryCompletion":1125,"completion":1126,"start":1127,"enrollment":1128,"conditions":1149,"interventions":1150},[56],[1130],[1113,1132],{"trials":1152,"activeCount":66},[],{"trials":1154,"activeCount":66},[],{"trials":1156,"activeCount":66},[],{"intervention":1158,"totalTrials":62,"cells":1159},"Adalimumab",{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1164,"PHASE3":1177,"PHASE4":1179,"NA":1181},{"trials":1161,"activeCount":66},[],{"trials":1163,"activeCount":66},[],{"trials":1165,"activeCount":66},[1166],{"nctId":1167,"briefTitle":1168,"status":200,"phases":1169,"primaryCompletion":1170,"completion":1170,"start":1171,"enrollment":21,"conditions":1172,"interventions":1176},"NCT02437253","Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI",[55,56],"2016-07","2015-05",[1173,1174,1175],"Mucopolysaccharidosis Type I","Mucopolysaccharidosis Type II","Mucopolysaccharidosis Type VI",[1158],{"trials":1178,"activeCount":66},[],{"trials":1180,"activeCount":66},[],{"trials":1182,"activeCount":66},[],{"intervention":1184,"totalTrials":62,"cells":1185},"TMP-SMX",{"EARLY_PHASE1":1186,"PHASE1":1188,"PHASE2":1190,"PHASE3":1205,"PHASE4":1207,"NA":1209},{"trials":1187,"activeCount":66},[],{"trials":1189,"activeCount":66},[],{"trials":1191,"activeCount":66},[1192],{"nctId":1193,"briefTitle":1194,"status":200,"phases":1195,"primaryCompletion":1196,"completion":1197,"start":1198,"enrollment":1199,"conditions":1200,"interventions":1203},"NCT03637400","Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment",[56],"2024-02-12","2025-06-30","2018-11-26",269,[1201,1202],"Methicillin-resistant Staphylococcus Aureus","Skin Infection",[1184,1204],"DOXY",{"trials":1206,"activeCount":66},[],{"trials":1208,"activeCount":66},[],{"trials":1210,"activeCount":66},[],{"intervention":1204,"totalTrials":62,"cells":1212},{"EARLY_PHASE1":1213,"PHASE1":1215,"PHASE2":1217,"PHASE3":1223,"PHASE4":1225,"NA":1227},{"trials":1214,"activeCount":66},[],{"trials":1216,"activeCount":66},[],{"trials":1218,"activeCount":66},[1219],{"nctId":1193,"briefTitle":1194,"status":200,"phases":1220,"primaryCompletion":1196,"completion":1197,"start":1198,"enrollment":1199,"conditions":1221,"interventions":1222},[56],[1201,1202],[1184,1204],{"trials":1224,"activeCount":66},[],{"trials":1226,"activeCount":66},[],{"trials":1228,"activeCount":66},[],{"intervention":1230,"totalTrials":62,"cells":1231},"L-Glutamine",{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1249,"PHASE4":1251,"NA":1253},{"trials":1233,"activeCount":66},[],{"trials":1235,"activeCount":66},[],{"trials":1237,"activeCount":66},[1238],{"nctId":1239,"briefTitle":1240,"status":861,"phases":1241,"primaryCompletion":1242,"completion":1243,"start":1244,"enrollment":11,"conditions":1245,"interventions":1248},"NCT00586209","L-Glutamine Therapy for Sickle Cell Anemia",[56],"2008-08-27","2009-11","2004-02-06",[1246,1247],"Sickle Cell Anemia","Thalassemia",[1230],{"trials":1250,"activeCount":66},[],{"trials":1252,"activeCount":66},[],{"trials":1254,"activeCount":66},[],{"intervention":1256,"totalTrials":62,"cells":1257},"Chlorhexidine gluconate",{"EARLY_PHASE1":1258,"PHASE1":1260,"PHASE2":1262,"PHASE3":1274,"PHASE4":1276,"NA":1278},{"trials":1259,"activeCount":66},[],{"trials":1261,"activeCount":66},[],{"trials":1263,"activeCount":66},[1264],{"nctId":1265,"briefTitle":1266,"status":200,"phases":1267,"primaryCompletion":808,"completion":202,"start":1268,"enrollment":1269,"conditions":1270,"interventions":1272},"NCT02589067","Decolonization of the Oropharynx, an Important and Neglected Reservoir of S. Aureus Colonization",[56],"2015-10",67,[1271],"S. Aureus Oropharyngeal Colonization",[1256,1273],"Saline Placebo",{"trials":1275,"activeCount":66},[],{"trials":1277,"activeCount":66},[],{"trials":1279,"activeCount":66},[],{"intervention":1273,"totalTrials":62,"cells":1281},{"EARLY_PHASE1":1282,"PHASE1":1284,"PHASE2":1286,"PHASE3":1292,"PHASE4":1294,"NA":1296},{"trials":1283,"activeCount":66},[],{"trials":1285,"activeCount":66},[],{"trials":1287,"activeCount":66},[1288],{"nctId":1265,"briefTitle":1266,"status":200,"phases":1289,"primaryCompletion":808,"completion":202,"start":1268,"enrollment":1269,"conditions":1290,"interventions":1291},[56],[1271],[1256,1273],{"trials":1293,"activeCount":66},[],{"trials":1295,"activeCount":66},[],{"trials":1297,"activeCount":66},[],{"intervention":1299,"totalTrials":62,"cells":1300},"Dimethandrolone Undecanoate",{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1317,"PHASE3":1319,"PHASE4":1321,"NA":1323},{"trials":1302,"activeCount":66},[],{"trials":1304,"activeCount":66},[1305],{"nctId":1306,"briefTitle":1307,"status":200,"phases":1308,"primaryCompletion":1309,"completion":1310,"start":1311,"enrollment":1312,"conditions":1313,"interventions":1316},"NCT01382069","Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men",[55],"2017-02","2017-05","2012-03",100,[1314,1315],"Healthy Men","Male Contraception",[1299],{"trials":1318,"activeCount":66},[],{"trials":1320,"activeCount":66},[],{"trials":1322,"activeCount":66},[],{"trials":1324,"activeCount":66},[],{"intervention":209,"totalTrials":62,"cells":1326},{"EARLY_PHASE1":1327,"PHASE1":1333,"PHASE2":1335,"PHASE3":1337,"PHASE4":1339,"NA":1341},{"trials":1328,"activeCount":66},[1329],{"nctId":198,"briefTitle":199,"status":200,"phases":1330,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":1331,"interventions":1332},[54],[207],[209,105,210],{"trials":1334,"activeCount":66},[],{"trials":1336,"activeCount":66},[],{"trials":1338,"activeCount":66},[],{"trials":1340,"activeCount":66},[],{"trials":1342,"activeCount":66},[],{"intervention":210,"totalTrials":62,"cells":1344},{"EARLY_PHASE1":1345,"PHASE1":1351,"PHASE2":1353,"PHASE3":1355,"PHASE4":1357,"NA":1359},{"trials":1346,"activeCount":66},[1347],{"nctId":198,"briefTitle":199,"status":200,"phases":1348,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":1349,"interventions":1350},[54],[207],[209,105,210],{"trials":1352,"activeCount":66},[],{"trials":1354,"activeCount":66},[],{"trials":1356,"activeCount":66},[],{"trials":1358,"activeCount":66},[],{"trials":1360,"activeCount":66},[],{"intervention":1362,"totalTrials":62,"cells":1363},"lanthanum carbonate",{"EARLY_PHASE1":1364,"PHASE1":1366,"PHASE2":1368,"PHASE3":1370,"PHASE4":1372,"NA":1374},{"trials":1365,"activeCount":66},[],{"trials":1367,"activeCount":66},[],{"trials":1369,"activeCount":66},[],{"trials":1371,"activeCount":66},[],{"trials":1373,"activeCount":66},[],{"trials":1375,"activeCount":66},[1376],{"nctId":1377,"briefTitle":1378,"status":200,"phases":1379,"primaryCompletion":1310,"completion":1310,"start":1311,"enrollment":1380,"conditions":1381,"interventions":1384},"NCT01581996","Fosrenol and Phosphorus Balance - Lanthanum Carbonate",[59],9,[1382,25,1383],"Chronic Kidney Failure","Disorders Associated With Peritoneal Dialysis",[1362],{"intervention":1386,"totalTrials":62,"cells":1387},"Bevacizumab",{"EARLY_PHASE1":1388,"PHASE1":1390,"PHASE2":1392,"PHASE3":1394,"PHASE4":1396,"NA":1398},{"trials":1389,"activeCount":66},[],{"trials":1391,"activeCount":66},[],{"trials":1393,"activeCount":66},[],{"trials":1395,"activeCount":66},[],{"trials":1397,"activeCount":66},[],{"trials":1399,"activeCount":66},[1400],{"nctId":1401,"briefTitle":1402,"status":1403,"phases":1404,"primaryCompletion":1405,"completion":1405,"start":1406,"enrollment":66,"conditions":1407,"interventions":1410},"NCT04067856","Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery","WITHDRAWN",[59],"2021-01-31","2020-01-01",[1408,1409],"Diabetic Macular Edema","Cataract",[1386],{"intervention":1412,"totalTrials":62,"cells":1413},"Minocycline 100 mg po bid for 6 months",{"EARLY_PHASE1":1414,"PHASE1":1416,"PHASE2":1418,"PHASE3":1420,"PHASE4":1422,"NA":1424},{"trials":1415,"activeCount":66},[],{"trials":1417,"activeCount":66},[],{"trials":1419,"activeCount":66},[],{"trials":1421,"activeCount":66},[],{"trials":1423,"activeCount":66},[],{"trials":1425,"activeCount":66},[1426],{"nctId":1427,"briefTitle":1428,"status":806,"phases":1429,"primaryCompletion":1430,"completion":1430,"start":1431,"enrollment":12,"conditions":1432,"interventions":1434},"NCT01779089","Minocycline and Proteinuria in Diabetic Nephropathy",[59],"2016-03","2009-02",[1433],"Diabetic Nephropathy",[1412]]